KinBio is a rapidly growing biotechnology company based in Rehovot, Israel focusing on developing biopharmaceuticals. Through our experienced team members, KinBio has fostered and developed a large portfolio of technologies for manufacturing generic versions of complex drugs, high quality biosimilars and biologics. Augmented by our global partnerships, KinBio is specialized in the research, development, manufacturing and global commercialization of biosimilars to treat and prevent diseases across several different therapeutic areas including CNS, inflammation, oncology, and osteoperosis. Our state of the art cGMP manufacturing plants consists of separate suites for the manufacturing of multi-product biologics bulk drug substances (BDS) and chemical synthesis active pharmaceutical ingredients (APIs) through FDA approved fully fledged sterile drug products plants.
